Brief: Kiniksa Pharmaceuticals Plans To Initiate A Phase 2b Trial With Abiprubart In Sjogren's Disease

Kiniksa Pharmaceuticals International

02/04/2024 12:40

April 2 (Reuters) - Kiniksa Pharmaceuticals Ltd
 KNSA.O :
    * KINIKSA PHARMACEUTICALS LTD: PLANS TO INITIATE A PHASE 2B
TRIAL
WITH ABIPRUBART IN SJOGREN'S DISEASE
    * KINIKSA PHARMACEUTICALS LTD: ANNOUNCED DATA FROM COHORT 4
OF
PHASE 2 CLINICAL TRIAL OF ABIPRUBART IN RHEUMATOID ARTHRITIS
    * KINIKSA PHARMACEUTICALS LTD: EXPECTS TO REMAIN CASH FLOW
POSITIVE ON AN ANNUAL BASIS WITHIN ITS CURRENT OPERATING PLAN
    * KINIKSA PHARMACEUTICALS LTD: ABIPRUBART DEVELOPMENT IN
SJOGREN'S
DISEASE FULLY FUNDED THROUGH PHASE 3

Source text for Eikon:  ID:nGNX1FyPKq 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))